The Effect of Low-Dose Corticosteroids on Short- and Long-Term Renal Outcome in Patients with Cholesterol Crystal Embolism

REFERENCES

• Scoble JE, O'Donnell PJ. Renal atheroembolic disease: The Cinderella of nephropathy? Nephrol Dial Transplant. 1996;11:1516–1517.
   Google Scholar
• Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology. 1987;38:769–784.
   PubMed Web of Science ®Google Scholar
• Thadhani RI, Camargo CA, Jr, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: Natural history based on 52 histologically proven cases. Medicine. 1995;74:350–358.
   Google Scholar
• Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: Experience with 22 histologically proven cases. Surgery. 1989;105:737–746.
   PubMed Web of Science ®Google Scholar
• Scolari F, Tardanico R, Zani R, Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis. 2000;36:1089–1109.
   PubMed Web of Science ®Google Scholar
• Scolari F, Ravani P, Pola A, Predictors of renal and patient outcomes in atheroembolic renal disease: A prospective study. J Am Soc Nephrol. 2003;14:1584–1590.
   PubMed Web of Science ®Google Scholar
• Scolari F, Ravani P, Gaggi R, The challenge of diagnosing atheroembolic renal disease. Clinical features and prognostic factors. Circulation. 2007;116:298–304.
   Google Scholar
• Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis. 1999;33:840–850.
   PubMed Web of Science ®Google Scholar
• Scolari F, Bracchi M, Valzorio B, An increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996;11:1607–1612.
   PubMed Web of Science ®Google Scholar
• Fabbian F, Catalano C, Lambertini D, Bordin V, Di Landro D. A possible role of corticosteroids in cholesterol embolization. Nephron. 1999;83:189–190.
   Google Scholar
• Graziani G, Santostasi S, Angelini C, Badalamenti S. Corticosteroids in cholesterol emboli syndrome. Nephron. 2001;87:371–373.
   Google Scholar
• Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens. 2001;14:831–834.
   Google Scholar
• Daimon S, Motita R, Ohtsuki N, LDL apheresis followed by corticosteroid therapy as a possible treatment of cholesterol crystal embolism. Clin Exp Nephrol. 2000;4: 352–355.
   Google Scholar
• Nakahama H, Sakaguchi K. Small dose oral corticosteroid treatment rapidly improved renal function in a patient with acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant. 2001;16:872–873.
   Google Scholar
• Tamura K, Umemura M, Yano H, Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol. 2003;7:67–71.
   Google Scholar
• Nakayama M, Nagata M, Hirano T, Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism. Clin Nephrol. 2006;66:232–239.
   Google Scholar
• Kaufman JL, Stark K, Brolin BE. Disseminated atheroemboli from extensive degenerative atherosclerosis of aorta. Surgery. 1987;102:63–70.
   PubMed Web of Science ®Google Scholar
• Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP. Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine. 1988;67:389–400.
   Google Scholar
• Matsuo S, Imai E, Horio M, Collaborators developing the Japanese equation for estimated GFR. Revised Equations for Estimated GFR From Serum Creatinine in Japan. Am J Kidney Dis. 2009;53:982–992.
   PubMed Web of Science ®Google Scholar
• Mittal BV, Alexander MP, Rennke HG, Singh AK. Atheroembolic renal disease: A silent masquerader. Kidney Int. 2008;73:126–130.
   Google Scholar
• Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol. 1993;13:489–493.
   PubMed Web of Science ®Google Scholar
• Maurizi CP, Barker AE, Truehart RE. Atheromatous emboli: A postmortem study with special reference to the lower extremities. Arch Pathol. 1968;86:528–534.
   Google Scholar
• Manganoni AM, Venturini M, Scolari F, The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. Br J Dermatol. 2004;150:1230–1231.
   Google Scholar
• Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med. 1987;147:1384–1385.
   PubMedGoogle Scholar
• Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol. 2001;12:1781–1787.
   Web of Science ®Google Scholar
• Hasegawa M, Kawashima S, Shikano M, The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. Am J Nephrol. 2000;20:263–267.
   Google Scholar
• Eliot RS, Kanjuh VI, Edwards JE. Atheromatous embolism. Circulation. 1964;30:611–618.
   Web of Science ®Google Scholar